Archive for October 10th, 2011

CXM 510k approval for Excellagen + INSM LGND news

Oct 10, 2011 No Comments by

Cardium Therapeutics (NYSE Amex: CXM) announced today that it has received 510k clearance from the FDA to market and sell Excellagen(TM) professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds. Directions for use indicate the application of Excellagen immediately following surgical debridement, which is routinely practiced […]

Daily News Read more